Blood/Immune System Cells TRIZ Cases
- Tumor-Infiltrating Lymphocyte Expansion With 4-1BB Agonist
Adding a 4-1BB agonist to IL-2 tumor fragment culture speeds TIL expansion and enriches tumor-reactive CD8+ cells for ACT.
- Cord Blood Treg Composition for Stable Pulmonary Immunosuppression
Umbilical cord blood-derived Treg cells improve lung targeting, stability, and repeat dosing for pulmonary disorder treatment.
- Miniaturized CAR Molecule Design for Durable Tumor Killing
A sub-300-amino-acid CAR design uses single co-stimulation and optimized CD3ζ signaling to improve persistence, tumor killing, and toxicity control.
- Dot-Patterned Cell Scaffolds for Stable Hematopoietic Differentiation
Dot-patterned cell scaffolds control cluster size and spacing to stabilize hematopoietic progenitor and leukocyte differentiation from pluripotent stem cells.
- T Cell Therapy Biomarkers for Early Apheresis Collection
Early apheresis collection with predictive biomarkers preserves T cell quality for CAR T manufacturing and improves patient stratification.
- Feeder-Free iPSC-Derived NK Cell Maturation for Cancer Killing
Feeder-free iPSC differentiation produces mature NK cells with strong cytotoxicity, reducing process complexity and contamination risk.
- Frozen Splenocyte Vaccine Potency Assay for Direct Immunogenicity
Frozen splenocytes activated by test and reference vaccine dilutions enable faster, more direct potency and immunogenicity measurement.